Evidence map›Paper›PMID 28150064›Full record

ReviewCurrent treatment options in cardiovascular medicine2017

Role of Imaging in Evaluating Infiltrative Heart Disease.

Sanjay Divakaran, Avinainder Singh, Bradley Collins, Tomas Vita, Rodney H Falk, Marcelo F Di Carli, Ron Blankstein

Open access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Current treatment options in cardiovascular medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. 3-Tesla cardiac magnetic resonance imaging in primary dilated cardiomyopathy.African journal of thoracic and critical care medicine · 2024
    Article
  3. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2022
    Article
  4. Same day comparison of PET/CT and PET/MR in patients with cardiac sarcoidosis.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Sanjay DivakaranDivision of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, 75 Francis Street, Boston, MA, 02115, USA.
Avinainder SinghCardiovascular Imaging Program, Departments of Medicine and Radiology, Brigham and Women's Hospital, 75 Francis Street, Boston, MA, 02115, USA.
Bradley CollinsCardiovascular Imaging Program, Departments of Medicine and Radiology, Brigham and Women's Hospital, 75 Francis Street, Boston, MA, 02115, USA.
Tomas VitaCardiovascular Imaging Program, Departments of Medicine and Radiology, Brigham and Women's Hospital, 75 Francis Street, Boston, MA, 02115, USA.
Rodney H FalkDivision of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, 75 Francis Street, Boston, MA, 02115, USA.
Marcelo F Di CarliDivision of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, 75 Francis Street, Boston, MA, 02115, USA.
Ron BlanksteinDivision of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, 75 Francis Street, Boston, MA, 02115, USA. rblankstein@partners.org.
Brigham and Women's Hospital · USHarvard University · US

Funding

Noninvasive Cardiovascular Imaging Research Training ProgramT32HL094301 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI Marcelo F DI CARLI · 2010 to 2026
$7.8M
NHLBI NIH HHS T32 HL094301
6 · The paper itself

Abstract

opinion statementInfiltrative heart disease is caused by the deposition of abnormal substances in the heart and can lead to abnormalities in cardiac function and electrical conduction. Advances in non-invasive cardiovascular imaging have allowed for improved diagnosis of infiltrative heart disease, as well as ways to track disease progression or regression, thus enabling a mechanism to follow response to therapy. In this review, we provide an overview of the role of imaging in the diagnosis and management of cardiac sarcoidosis (CS) and cardiac amyloidosis (CA), as well as outline a proposed algorithm for using non-invasive cardiovascular imaging for evaluating these conditions.

Indexed as

Cardiac amyloidosisCardiovascular imagingImagingInfiltrative heart disease

Identifiers

PMID28150064
PMCPMC5460755
OpenAlexW2585729488

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.